610 likes | 747 Views
Health Care Without Harm Europe Endocrine Disruptors in the Health Care Sector Wednesday 24th September 15:30-16:30 CEST. What are EDCs & How does exposure affect human health ?. R. Thomas Zoeller Biology Department College of Natural Sciences. What is an Endocrine Disrupting Chemical?.
E N D
Health Care Without Harm Europe Endocrine Disruptors in the Health Care Sector Wednesday 24th September 15:30-16:30 CEST
What are EDCs&How does exposure affect human health? R. Thomas Zoeller Biology Department College of Natural Sciences
What is an Endocrine Disrupting Chemical? • “An ED is an exogenous chemical or mixture of chemicals that can interfere with any aspect of hormone action” – Endocrine Society • “interfere” means to trigger or block hormone action • “any aspect” means to interfere with the hormone receptor or with the delivery of the hormone to the receptor • “hormone action” means “what the hormone does”
What is an Endocrine Disrupting Chemical? • To test if a chemical interferes with hormone action, you have to know what the hormone does. • The problem is that hormones do different things in different “places” at different times! • So EDCs may interfere with a hormone’s action selectively…. • Could be receptor isoform specific • Could be “metabolism” specific • Almost certain is differentially sensitive
PCB exposure is associated with cognitive deficits SchantzSL, Widholm JJ, Rice DC. Environ Health Perspect. 2003 Mar;111(3):357-576.
Thyroid hormone deficiency produces effects on cognitive function that are similar to that of PCB exposureTherefore, could PCB exposure be producing neurocognitive deficits by reducing thyroid hormone levels?
PCB exposure in animals almost uniformly causes a reduction in serum total and free (not shown) T4.
If PCB – induced reduction in serum T4 is predictive of “downstream” effects, then PCB exposure should reduce the expression of thyroid hormone responsive genes in the developing brain.
PCB effects on serum T4 were not consistent with PCB effect on TH-regulated genes RC3 mRNA in Dentate Gyrus (Density) 60 Cx 55 * * 50 45 DG RC3 40 35 30 25 0 mg/kg 1 mg/kg 4 mg/kg 8 mg/kg Pseudocolor image of Autoradiogram following in situ hybridization for RC3 mRNA A1254 Dose
Are there TR agonists among PCB congeners? Non-ortho PCB congener Coplanar Dioxin-like Mono-ortho PCB congener Non-coplanar Di-ortho PCB congener Non-coplanar PCBs in in vitro and in vivo studies Gauger, KJ. et al, (2007);Envir. Health Pers. 115(11), 1623-1630
Only the right mixture activated the TR PCBs in in vitro and in vivo studies Gauger, KJ. et al, (2007);Envir. Health Pers. 115(11), 1623-1630
4. Hypothesis TR TR TH target genes TRE PCB 126 coplanar ARNT AHR CYP1A1 XRE CYP1A1 PCB 105 PCB 138 PCB 118 PCB 153 non-coplanar OH OH PCBs in in vitro and in vivo studies
Testing the hypothesis in humans • If environmental chemicals (e.g., PCBs) can be “activated” by CYP1A1 to form TR agonists which then drive (±) TH-response genes independent of serum TH, then: • CYP1A1 expression should be correlated with the expression of TH response genes?
Conclusions • Animal studies demonstrate that some EDCs can interfere with thyroid hormone action in tissues (e.g., developing brain) in a manner that is not reflected in serum thyroid hormone levels. • Human studies identify associations between toxicant exposures and measures of cognitive function (as well as other outcomes), but relationships with measures of thyroid function have been inconsistent. • Capturing indices of hormone action in tissues will be essential to translate experimental studies to the human population.
“We live in a chemical soup” Is there summation or synergy? • Ingestion: food, dust, water • Inhalation: gases, air particles • Dermal absorption: personal care, dust • Breast Milk
Most Vulnerable Time for Exposure All of the chemicals highlighted before are found in cord blood at birth. But, each baby has a total of about 100 chemicals “on board”. One study. 10 cord samples. 287 commercial chemicals, pesticides, and pollutants.
Health Care Without Harm Europe Endocrine Disruptors in the Health Care Sector Wednesday 24th September 15:30-16:30 CEST
Children are a product of theirenvironment Gavin W. ten Tusscher, M.D., Ph.D., paediatrician Department of Paediatrics and Neonatology Westfriesgasthuis, Hoorn, Netherlands
Overview • What’s the problem? • What’s the danger? • What’s the solution? Gavin ten Tusscher
Health care: a source, but not the primary source, of exposure to toxics Gavin ten Tusscher
Sources of exposure to toxic chemicals in hospitals Gavin ten Tusscher
Most at risk • Foetus, prematurely born, small for gestational age, seriously ill child • Higher fat : water ratio but often less total body fat, long periods of exposure (in hospital) • Often life-long accumulative exposure • Organs (brain) still developing • Less effective blood-brain and blood-testis barrier Gavin ten Tusscher
DEHP • Softeners in plastic (PVC) • Known for 30 years that it leaks out of medical devices • Shown to leak from: • nasogastric tubes, respiratory tubes, endotracheal tubes, umbilical catheters, PVC blood bags, transfusion tubing systems, haemodialysis systems, cardiopulmonary bypass, continuous peritoneal dialysis, ECMO, infusion tubing • Suspected of teratogenicity and endocrine disruption Gavin ten Tusscher
DEHP and children • highly lipophilic (over placenta, in breast milk) • pancreatic lipase most important detoxifier • much lower levels of pancreatic lipase in neonates • greater absorption in children • vulnerable developmental windows Gavin ten Tusscher
NICU exposure to DEHP • 6 premature infants expected to have i.v. infusion for > 2 weeks included • 7 urine samples per infant • DEHP metabolites (mEHHP, mEOHP, mEHP) measured by CDC • 41 samples (1 sample no urine extractable) • 33 samples positive for all 3 metabolites Calafat et al. Pediatrics 2004;113(5):e429-3 Gavin ten Tusscher
Cohort Gavin ten Tusscher
Results Gavin ten Tusscher
Discussion • geometric mean mEHP (100 ng/mL) prems • significantly higher than 19 toddlers 12 – 18 months (4.6 ng/mL) • 26 fold higher than US median for children 6 – 11 yrs • mEHHP and mEOHP 1-2 order of magnitude higher than US population (62 adults and children) • no correlation with specific procedure, GA, birth weight Gavin ten Tusscher
In utero exposure vs gestational age • Cordblood samples obtained in 84 consecutivenewborns (82 singletons, 2 twins) • General practicehospital • 39 males, 45 females • 11 preterm, 3 VSGA, 4 SGA • No in vitro fertilisation • Sampling withglassdevices Latini et al. Environ Health Perspect 2003;111(14):1783-5 Gavin ten Tusscher
Results • Logistic regression: • Significant inverse relation mEHP & GA at birth (38.16 ± 2.34 vs 39.35 ± 1.35 wks) • OR 1.5 (CI 1.013-2.21) presence/absence mEHP Gavin ten Tusscher
Exposure • Endotracheal tubes show 6 – 12 % loss of DEHP during use most probably into the lungs Latini & Avery. Acta Paediatr 1999;88(10):1174-75 • Priming of ECMO circuits with saline increased circuit degradation Karle et al. Crit Care Med 1997;25(4):696-703 • DEHP negative infants showed 6.1 to 21.6 mcg/mL after a single exchange transfusion • DEHP found in lung tissue in preterms after mechanical ventilation Roth et al. Eur J Pediatr 1988;147(1):42-6 Gavin ten Tusscher
DEHP • “normal” daily exposure 3-30 mcg/kg BW/day • NICU enteral nutrition 40-140 mcg/kg BW/day • NICU parental nutrition up to 2500 mcg/kg BW/day !! • Total daily intake in all children (< 19 yrs) > adults Gavin ten Tusscher
Bear in mind • DEHP toxicity shown in animal studies (long term toxicity & tissue deposition) • DEHP exposure is life-long, ubiquitous environmental contaminant • No longer in toys for children < 3 yrs (EU 1999/815/EG) • US FDA consider NICU patients at particular risk Gavin ten Tusscher
American Medical Association H-135.945 Encouraging Alternatives to PVC/DEHP Products in Healthcare AMA: (1) encourages hospitals and physicians to reduce and phase out polyvinyl chloride (PVC) medical device products, especially those containing Di(2-ethylhexyl)phthalate (DEHP), and urge adoption of safe, cost-effective, alternative products where available; and (2) urges expanded manufacturer development of safe, cost-effective alternative products to PVC medical device products, especially those containing DEHP. (BOT Action in response to referred for decision Res. 502, A-06) Gavin ten Tusscher
Summarising • Clear indications of DEHP exposure from medical devices • Animal studies show negative health effects • Exposure scenario in plastic laden environment • Increased exposure in infants Gavin ten Tusscher
PrecautionaryPrinciple • Safer alternatives for almost all products • We need to actively choose better alternatives • Choose PVC-free/DEHP-free • “When in doubt, throw it out” Gavin ten Tusscher
Database Gavin ten Tusscher
Not easy … Gavin ten Tusscher
Not easy … Gavin ten Tusscher